<DOC>
	<DOCNO>NCT02910271</DOCNO>
	<brief_summary>AIMS : Determining clinical feature prevalence peripheral artery disease ( PAD ) asymptomatics patient type 1 diabetes mellitus ( T1DM ) check validity current recommendation regard PAD screen T1DM . METHODOLOGY : An observational cross-sectional prevalence study . The whole group patient ( sample size calculate : 299 patient ) make Edinburgh Questionnaire detect classic symptom intermittent claudication , verify absence symptom exclusion criterion , include study . All patient undergo assessment clinical parameter relate T1DM classic cardiovascular risk factor , well , analytical assessment lipid profile , HbA1c level , proinflammatory profile oxidative stress status . They also undergo comprehensive anthropometric assessment include office blood pressure ( BP ) monitor ambulatory 24-hours BP monitoring patient indication routine clinical practice , assessment cardioautonomic function , lastly ankle-brachial index ( ABI ) Doppler ultrasound , context routine clinical practice patient clinical indication , extraordinary procedure participate study patient meet criterion screen accord current recommendation .</brief_summary>
	<brief_title>Clinical Features Prevalence Asymptomatic Peripheral Artery Disease Patients With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>INTRODUCTION : PAD condition characterize atherosclerotic occlusive disease low extremity . While PAD major risk factor lower-extremity amputation , also accompany high likelihood symptomatic cardiovascular cerebrovascular disease . PAD often subtle presentation patient diabetes without diabetes . In contrast focal proximal atherosclerotic lesion PAD find typically high-risk patient , diabetic patient lesion likely diffuse distal . Importantly , PAD individual diabetes usually accompany peripheral neuropathy impair sensory feedback , thus classic history claudication may less common . Data Framingham Heart Study reveal 20 % PAD symptomatic patient diabetes mellitus , probably , data greatly underestimate PAD prevalence . As well , report PAD , one-half patient asymptomatic atypical symptom , one-third claudication , rest severe disease . Also , patient diabetes identify PAD prone sudden ischemia secondary arterial thrombosis pivotal event lead neuroischemic ulceration infection rapidly result acute presentation critical limb ischemia risk amputation . However , important note , clinical data PAD diabetes , become population study randomize clinical trial , make exclusively type 2 patient , frequently , analyze patient diabetes diagnosis , without distinction T1 T2 subtypes . Thus , although much know regard PAD general population , assessment management PAD diabetes less clear , especially patient T1DM diagnosis . In 2003 , Consensus Development Conference hold regard PAD diabetes . After series lecture expert field endocrinology , cardiology , vascular surgery , orthopedic surgery , podiatry , nursing , vascular medicine panel ask answer question epidemiology impact PAD people diabetes , diagnosis treatment PAD , always generalize management T1 T2 diabetes , unique term `` diabetes '' . PAD diagnose patient diabetes clinical importance two reason : ) identify patient high risk subsequent cardiovascular cerebrovascular disease ii ) diagnose treat PAD , may associate functional disability limb loss . Preventive measure patient subclinical disease make possible avoid acute chronic complication . Therefore , knowledge true prevalence PAD T1DM relevant set screen indication patient , give frequently asymptomatic might clinically different presentation compare type 2 diabetes patient . AIMS : The main objetive work determine clinical feature prevalence PAD asymptomatics patient T1DM check validity current recommendation regard PAD screen T1DM . METHODOLOGY : Observational cross-sectional prevalence study conduct . A consecutive population type 1 patient clinic ( sample size calculate : 299 patient ) screen Edinburgh Questionnaire ( Leng &amp; Fowkes 1992 ) detect classic symptom intermittent claudication , verify absence symptom exclusion criterion , include study . - All patient undergo assessment clinical parameter relate T1DM ( year inicial diagnosis , insulin treatment , metabolic control , microvascular chronic complication ) , cardiovascular risk factor ( hypertension , dyslipidemia , chronic smoking ) , prior cardiovascular disease ( coronary cerebrovascular disease ) , well , analytical assessment include lipid profile , HbA1c level , proinflammatory marker ( C-reactive protein , homocysteine ) oxidative stress status . - They undergo comprehensive anthropometric evaluation : weight , height , body mass index [ BMI ( kg / m2 ) ] , abdominal hip circumference , body fat percentage total body weight bioelectrical impedance . - Office BP ambulatory 24-hours BP monitoring patient indication routine clinical practice ( Mancia G et al 2013 ) . - Assessment cardioautonomic function : orthostatism systolic diastolic BP , orthostatism heart rate , heart rate variability expiration / inspiration , Valsalva orthostatic . - Diabetic foot exploration ( include bilateral peripheral pulse , Neuropathy Symptoms Score questionnaire , monofilament exploration , calibrate tune fork ) . - The ABI perform Doppler ultrasound ( HADECO® Minidop EN 8 Mhz ) , context routine clinical practice patient clinical indication , extraordinary procedure participate study patient meet criterion screen accord current recommendation . The ABI measure posterior tibial pedia artery . Interpretation ABI wil follow : Average : 0.90 1.20 ; mild arterial obstruction : 0.70 0.89 ; moderate arterial obstruction : 0.40 0.69 ; severe arterial obstruction &lt; 0.40 ; poorly compressible artery &gt; 1.20 . In patient ABI &gt; 1.20 &lt; 0.9 , examination complete recommended guideline asymptomatic PAD diagnosis assess graphic record blood flow assessment index finger-arm .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Previous diagnosis T1DM 30 year age . DM diagnostic criterion : DM cardinal symptom ( polyuria , polydipsia , unexplained weight loss ) plasma glucose ≥ 200 mg / dl , diagnosis diabetic ketoacidosis ( DKA ) . fast plasma glucose ( ≥ 8 h ) ≥ 126 mg / dl . plasma glucose 2 h test oral glucose tolerance test ( 75 g glucose ) ≥ 200 mg / dl . glycosylated hemoglobin ( HbA1c ) ≥ 6.5 % [ certify National method Glicohemoglobin Standardized Program ( NGSP ) standardize accord Diabetes Control Complication Trial trial ( DCCT ) ] . The criterion b , c require confirmation , except case hyperglycemia acute decompensation ( criterion ) . Positive determination autoantibody serum marker immune destruction antigen cytoplasm islet cell ( ICA ) , antiinsulin ( AAI ) , / anti protein glutamate decarboxylase ( GADA ) inicial diagnosis time course disease . Acceptance participation study sign inform consent . Prior diagnosis PAD , diabetic foot , leg amputation symptom line PAD accord Edinburgh questionnaire intermittent claudication . Diagnosis type 2 diabetes , gestational diabetes , LADA MODY diabetes . Current pregnancy , institutionalized terminal illness subject . Refusal participate study sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>